Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Eur J Cardiothorac Surg

Retrieve available abstracts of 71 articles:
HTML format
Text format



Single Articles


    November 2017
  1. SAWABATA N
    Pulmonary wedge resection for Stage I non-small-cell lung cancer: possible alternative strategy to lobectomy.
    Eur J Cardiothorac Surg. 2017 Nov 3. doi: 10.1093.
    PubMed     Text format    


    September 2017
  2. GU C, Pan X, Chen Y, Yang J, et al
    Short-term and mid-term survival in bronchial sleeve resection by robotic system versus thoracotomy for centrally located lung cancer.
    Eur J Cardiothorac Surg. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. DECALUWE H, Petersen RH, Brunelli A, Pompili C, et al
    Multicentric evaluation of the impact of central tumour location when comparing rates of N1 upstaging in patients undergoing video-assisted and open surgery for clinical Stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. TSUTANI Y, Tsubokawa N, Ito M, Misumi K, et al
    Postoperative complications and prognosis after lobar resection versus sublobar resection in elderly patients with clinical Stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Sep 6. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2017
  5. YANG S, Guo W, Chen X, Wu H, et al
    Early outcomes of robotic versus uniportal video-assisted thoracic surgery for lung cancer: a propensity score-matched study.
    Eur J Cardiothorac Surg. 2017 Aug 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. ABAH U, Casali G, Batchelor TJP, Internullo E, et al
    Pathological lymph node involvement is not a predictor of adverse outcomes in patients undergoing thoracoscopic lobectomy for lung cancer.
    Eur J Cardiothorac Surg. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. UDA K, Matsui H, Fushimi K, Yasunaga H, et al
    Preoperative short-term plus postoperative physical therapy versus postoperative physical therapy alone for patients undergoing lung cancer surgery: retrospective analysis of a nationwide inpatient database.
    Eur J Cardiothorac Surg. 2017 Aug 18. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2017
  8. ZEHNDER A, Kocher GJ, Seitz M, Schmid RA, et al
    IgG4-related disease of the lung: a rare differential diagnosis to lung cancer after positive positron emission tomography and biopsy.
    Eur J Cardiothorac Surg. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. BUGGE AS, Lund MB, Valberg M, Brustugun OT, et al
    Cause-specific death after surgical resection for early-stage non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. GUIRAO MONTES A, Molins Lopez-Rodo L, Ramon Rodriguez I, Sunyer Dequigiovanni G, et al
    Lung cancer diagnosis by trained dogs.
    Eur J Cardiothorac Surg. 2017 Jul 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. ENDO S, Ikeda N, Kondo T, Nakajima J, et al
    Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014-2015.
    Eur J Cardiothorac Surg. 2017 Jul 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. PERIKLEOUS P, Bilancia R, Oey I, Waller DA, et al
    Hybrid bilobectomy for treatment of an early-stage lung cancer in a patient with severe emphysema using the benefits of lung volume reduction.
    Eur J Cardiothorac Surg. 2017 Jul 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. YANG CC, Fong Y, Lin LC, Que J, et al
    The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices.
    Eur J Cardiothorac Surg. 2017 Jul 4. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2017
  14. CAGINI L, Balloni S, Ludovini V, Andolfi M, et al
    Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer.
    Eur J Cardiothorac Surg. 2017 Jun 19. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  15. SEKIHARA K, Hishida T, Yoshida J, Oki T, et al
    Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?
    Eur J Cardiothorac Surg. 2017 May 8. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  16. FILOSSO PL, Guerrera F, Evangelista A, Galassi C, et al
    Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database.
    Eur J Cardiothorac Surg. 2017 Apr 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. BENDIXEN M, Licht PB
    Video-assisted thoracoscopic surgery versus open lobectomy for lung cancer: time for a randomized trialdagger.
    Eur J Cardiothorac Surg. 2017 Apr 27. doi: 10.1093.
    PubMed     Text format    


  18. KARENOVICS W, Licker M, Ellenberger C, Christodoulou M, et al
    Short-term preoperative exercise therapy does not improve long-term outcome after lung cancer surgery: a randomized controlled studydagger.
    Eur J Cardiothorac Surg. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. WELTER S, Arfanis E, Christoph D, Hager T, et al
    Growth patterns of pulmonary metastases: should we adjust resection techniques to primary histology and size?dagger.
    Eur J Cardiothorac Surg. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. DZIEDZIC R, Zurek W, Marjanski T, Rudzinski P, et al
    Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registrydagger.
    Eur J Cardiothorac Surg. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. ANDERSON KL JR, Mulvihill MS, Yerokun BA, Speicher PJ, et al
    Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival.
    Eur J Cardiothorac Surg. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  22. SCHIRREN J, Schirren M, Lampl L, Sponholz S, et al
    Surgery for pulmonary metastases: quo vadis?
    Eur J Cardiothorac Surg. 2017;51:408-410.
    PubMed     Text format    


    February 2017
  23. BILLE A, Woo KM, Ahmad U, Rizk NP, et al
    Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.
    Eur J Cardiothorac Surg. 2017 Feb 13. doi: 10.1093.
    PubMed     Text format    


  24. SZANTO Z, Benko I, Jakab L, Szalai G, et al
    The use of a smartphone application for fast lung cancer risk assessmentdagger.
    Eur J Cardiothorac Surg. 2017 Feb 10. doi: 10.1093.
    PubMed     Text format    


  25. DENG HY, Wang YC, Ni PZ, Li G, et al
    Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017;51:203-210.
    PubMed     Text format    


    January 2017
  26. PEDERSEN JH, Rzyman W, Veronesi G, D'Amico TA, et al
    Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.
    Eur J Cardiothorac Surg. 2017 Jan 30. pii: ezw418. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. MOKHLES S, Macbeth F, Treasure T, Younes RN, et al
    Systematic lymphadenectomy versus sampling of ipsilateral mediastinal lymph-nodes during lobectomy for non-small-cell lung cancer: a systematic review of randomized trials and a meta-analysis.
    Eur J Cardiothorac Surg. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format    


  28. MATSUNAGA T, Suzuki K, Takamochi K, Oh S, et al
    What is the radiological definition of part-solid tumour in lung cancer?dagger.
    Eur J Cardiothorac Surg. 2017 Jan 24. pii: ezw344. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. POMPILI C, Velikova G, White J, Callister M, et al
    Poor preoperative patient-reported quality of life is associated with complications following pulmonary lobectomy for lung cancer.
    Eur J Cardiothorac Surg. 2017 Jan 12. pii: ezw363. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2016
  30. LI S, Wang Z, Huang J, Fan J, et al
    Systematic review of prognostic roles of body mass index for patients undergoing lung cancer surgery: does the 'obesity paradox' really exist?
    Eur J Cardiothorac Surg. 2016 Dec 30. pii: ezw386. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. GUERRERA F, Renaud S, Tabbo F, Voegeli' AC, et al
    Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomasdagger.
    Eur J Cardiothorac Surg. 2016 Dec 15. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2016
  32. SHIONO S, Okumura T, Boku N, Hishida T, et al
    Outcomes of segmentectomy and wedge resection for pulmonary metastases from colorectal cancer.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available


    September 2016
  33. DENG HY, Wang YC, Ni PZ, Li G, et al
    Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available


    July 2016
  34. LEE GD, Kim DK, Jang SJ, Choi SH, et al
    Significance of R1-resection at the bronchial margin after surgery for non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available


  35. RIQUET M, Arame A, Pricopi C, Foucault C, et al
    Visceral pleura and pN involvement in lung cancer.
    Eur J Cardiothorac Surg. 2016;50:193.
    PubMed     Text format    


  36. HOFFERBERTH SC, Grinstaff MW, Colson YL
    Nanotechnology applications in thoracic surgery.
    Eur J Cardiothorac Surg. 2016;50:6-16.
    PubMed     Text format     Abstract available


  37. DECALUWE H, Stanzi A, Dooms C, Fieuws S, et al
    Central tumour location should be considered when comparing N1 upstaging between thoracoscopic and open surgery for clinical stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2016;50:110-7.
    PubMed     Text format     Abstract available


  38. STAMENOVIC D, Bostanci K, Messerschmidt A, Jahn T, et al
    Fissureless fissure-last video-assisted thoracoscopic lobectomy for all lung lobes: a better alternative to decrease the incidence of prolonged air leak?
    Eur J Cardiothorac Surg. 2016;50:118-23.
    PubMed     Text format     Abstract available


  39. CHIAPPETTA M, Nachira D, Margaritora S, Granone P, et al
    Are digital devices routinely useful in thoracic surgery or are they helpful only in selected cases?
    Eur J Cardiothorac Surg. 2016;50:192.
    PubMed     Text format    


    June 2016
  40. PIRRO M, Cagini L, Mannarino MR, Andolfi M, et al
    Reduced survival in patients with early-stage non-small-cell lung cancer is associated with high pleural endothelial progenitor cell levels.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available


  41. KIRCHEVA DY, Husain AN, Watson S, Kindler HL, et al
    Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
    Eur J Cardiothorac Surg. 2016;49:1642-7.
    PubMed     Text format     Abstract available


  42. WATANABE K, Tsuboi M, Sakamaki K, Nishii T, et al
    Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2016;49:1624-31.
    PubMed     Text format     Abstract available


  43. WALLER DA
    The staging of malignant pleural mesothelioma: are we any nearer to squaring the circle?
    Eur J Cardiothorac Surg. 2016;49:1648-9.
    PubMed     Text format    


    May 2016
  44. RIQUET M, Legras A, Pricopi C, Le-Pimpec-Barthes F, et al
    Microscopic pN2 in lung cancer: a better prognosis?
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format    


  45. LIU J, Cui F, Pompeo E, Gonzalez-Rivas D, et al
    The impact of non-intubated versus intubated anaesthesia on early outcomes of video-assisted thoracoscopic anatomical resection in non-small-cell lung cancer: a propensity score matching analysis.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available


  46. SWANSON SJ
    The value of video-assisted thoracoscopic surgery: follow the money!
    Eur J Cardiothorac Surg. 2016;49:1496.
    PubMed     Text format    


    April 2016
  47. BOLUKBAS S, Eberlein M
    Biomarker-driven early lung cancer therapy: the future is now?
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format    


  48. LIN JT, Yang XN, Zhong WZ, Liao RQ, et al
    Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available


  49. MENG D, Zhou Z, Wang Y, Wang L, et al
    Lymphadenectomy for clinical early-stage non-small-cell lung cancer: a systematic review and meta-analysis.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available


  50. BRUNELLI A
    Ventilatory efficiency slope: an additional prognosticator after lung cancer surgery.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format    


  51. SHAFIEK H, Valera JL, Togores B, Torrecilla JA, et al
    Risk of postoperative complications in chronic obstructive lung diseases patients considered fit for lung cancer surgery: beyond oxygen consumption.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available


  52. ROCCO G, Nason K, Brunelli A, Varela G, et al
    Management of stage IIIA (N2) non-small-cell lung cancer: a transatlantic perspectivedagger.
    Eur J Cardiothorac Surg. 2016;49:1025-7.
    PubMed     Text format    


    March 2016
  53. DZIEDZIC D, Rudzinski P, Langfort R, Orlowski T, et al
    Results of surgical treatment and impact on T staging of non-small-cell lung cancer adjacent lobe invasion.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available


  54. WOOD DE
    Re: Lung cancer screening: did we really need a randomized controlled trial?
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format    


  55. AL-AYOUBI AM, Flores RM
    Lung cancer screening: did we really need a randomized controlled trial?
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available


  56. FUKUI M, Takamochi K, Matsunaga T, Oh S, et al
    Risk of the preoperative underestimation of tumour size of lung cancer in patients with idiopathic interstitial pneumoniasdagger.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available


    February 2016
  57. GARELLI E, Renaud S, Falcoz PE, Weingertner N, et al
    Microscopic N2 disease exhibits a better prognosis in resected non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available


  58. THOMAS PA, Falcoz PE, Bernard A, Le Pimpec-Barthes F, et al
    Bilobectomy for lung cancer: contemporary national early morbidity and mortality outcomes.
    Eur J Cardiothorac Surg. 2016;49:e38-43.
    PubMed     Text format     Abstract available


    January 2016
  59. NAGAYASU T, Sato S, Yamamoto H, Yamasaki N, et al
    The impact of certification of general thoracic surgeons on lung cancer mortality: a survey by The Japanese Association for Thoracic Surgerydagger.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available


  60. EDWARDS JP, Datta I, Hunt JD, Stefan K, et al
    Forecasting the impact of stereotactic ablative radiotherapy for early-stage lung cancer on the thoracic surgery workforcedagger.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available


  61. XIE D, Wang H, Fei K, Chen C, et al
    Single-port video-assisted thoracic surgery in 1063 cases: a single-institution experiencedagger.
    Eur J Cardiothorac Surg. 2016;49 Suppl 1:i31-6.
    PubMed     Text format     Abstract available


  62. GONZALEZ-RIVAS D, Yang Y, Stupnik T, Sekhniaidze D, et al
    Uniportal video-assisted thoracoscopic bronchovascular, tracheal and carinal sleeve resectionsdagger.
    Eur J Cardiothorac Surg. 2016;49 Suppl 1:i6-16.
    PubMed     Text format     Abstract available


  63. NG CS, Yu SC, Lau RW, Yim AP, et al
    Hybrid DynaCT-guided electromagnetic navigational bronchoscopic biopsydagger.
    Eur J Cardiothorac Surg. 2016;49 Suppl 1:i87-8.
    PubMed     Text format     Abstract available


  64. HIRAI K, Takeuchi S, Usuda J
    Single-incision thoracoscopic surgery and conventional video-assisted thoracoscopic surgery: a retrospective comparative study of perioperative clinical outcomesdagger.
    Eur J Cardiothorac Surg. 2016;49 Suppl 1:i37-41.
    PubMed     Text format     Abstract available


    December 2015
  65. VAN SCHIL PE
    Stage IIIA-N2 non-small-cell lung cancer: from 'surprise' involvement to surgical nightmare.
    Eur J Cardiothorac Surg. 2015.
    PubMed     Text format    


    May 2015
  66. MARJANSKI T, Wnuk D, Bosakowski D, Szmuda T, et al
    Patients who do not reach a distance of 500 m during the 6-min walk test have an increased risk of postoperative complications and prolonged hospital stay after lobectomy.
    Eur J Cardiothorac Surg. 2015;47:e213-9.
    PubMed     Text format     Abstract available


  67. JIMENEZ MF
    Uniportal versus standard video-assisted thoracoscopic surgery for lung lobectomy: changing the standards requires scientific evidence.
    Eur J Cardiothorac Surg. 2015;47:916.
    PubMed     Text format    


    March 2015
  68. TAKENAKA T, Takenoyama M, Yamaguchi M, Toyozawa R, et al
    Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2015;47:550-5.
    PubMed     Text format     Abstract available


  69. RIED M, Lehle K, Neu R, Diez C, et al
    Assessment of cisplatin concentration and depth of penetration in human lung tissue after hyperthermic exposure.
    Eur J Cardiothorac Surg. 2015;47:563-6.
    PubMed     Text format     Abstract available


  70. JEON JH, Kang CH, Kim HS, Seong YW, et al
    Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resection.
    Eur J Cardiothorac Surg. 2015;47:556-62.
    PubMed     Text format     Abstract available


    January 2015
  71. OBESO CARILLO GA, Casais Pampin R, Legarra Calderon JJ, Pradas Montilla G, et al
    Primary pulmonary artery sarcoma: a new surgical technique for pulmonary artery reconstruction using a self-made stapled bovine pericardial graft conduit.
    Eur J Cardiothorac Surg. 2015;47:188-90.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: